Cargando…
Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics
BACKGROUND: A 15-gene expression profile test has been clinically validated and is widely utilized in newly diagnosed uveal melanoma (UM) patients to assess metastatic potential of the tumor. As most patients are treated with eye-sparing radiotherapy, there is limited tumor tissue available for test...
Autores principales: | Plasseraud, Kristen M., Wilkinson, Jeff K., Oelschlager, Kristen M., Poteet, Trisha M., Cook, Robert W., Stone, John F., Monzon, Federico A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545042/ https://www.ncbi.nlm.nih.gov/pubmed/28778171 http://dx.doi.org/10.1186/s13000-017-0650-3 |
Ejemplares similares
-
Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
por: Cook, Robert W., et al.
Publicado: (2018) -
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
por: Field, Matthew G., et al.
Publicado: (2016) -
Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling
por: Schefler, Amy C, et al.
Publicado: (2020) -
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses
por: Aaberg, Thomas M, et al.
Publicado: (2014) -
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study
por: Plasseraud, Kristen Meldi, et al.
Publicado: (2016)